4//SEC Filing
Sachs Jessica 4
Accession 0000899243-22-000694
CIK 0001622229other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:25 PM ET
Size
5.0 KB
Accession
0000899243-22-000694
Insider Transaction Report
Form 4
Sachs Jessica
Chief Medical Officer
Transactions
- Award
Common Stock
2021-12-31$6.82/sh+674$4,595→ 674 total
Footnotes (1)
- [F1]The shares were acquired under the Cogent Biosciences, Inc. 2018 Employee Stock Purchase Plan. The transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001782545
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 9:25 PM ET
- Size
- 5.0 KB